About this FactMed analysis covering adverse side effect reports of DYAZIDE patients who developed ADHESION.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 7 individuals taking DYAZIDE reported ADHESION to the FDA. A total of 4693 DYAZIDE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between DYAZIDE and ADHESION. In doing so, we compare DYAZIDE with other drugs that cause ADHESION, to help you evaluate whether or not DYAZIDE causes ADHESION. Likewise, this page shows the most highly-reported side effects of DYAZIDE, so you can see if ADHESION ranks among DYAZIDE's most well-known side effects.
Summary Statistics
Reports of DYAZIDE causing ADHESION: 7
Reports of any side effect of DYAZIDE : 4693
Percentage of DYAZIDE patients where ADHESION is a reported side effect: 0.1492%

FDA reports of any drug causing ADHESION : 955
Average percentage for all medicated patients where ADHESION is reported as a complication: 0.0060%

Physician opinion on DYAZIDE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing DYAZIDE:
HYPERTENSION ( 556 patients )
DRUG USE FOR UNKNOWN INDICATION ( 218 patients )
OEDEMA ( 84 patients )
BLOOD PRESSURE ( 77 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 74 patients )
FLUID RETENTION ( 56 patients )
DIURETIC THERAPY ( 52 patients )
MENIERE'S DISEASE ( 45 patients )
OEDEMA PERIPHERAL ( 27 patients )
SWELLING ( 16 patients )
BLOOD PRESSURE ABNORMAL ( 10 patients )
ILL-DEFINED DISORDER ( 7 patients )
POLYURIA ( 5 patients )
CARDIAC DISORDER ( 5 patients )
CORONARY ARTERY DISEASE ( 5 patients )
VERTIGO ( 4 patients )
DEHYDRATION ( 3 patients )
ESSENTIAL HYPERTENSION ( 3 patients )
CORONARY ARTERY BYPASS ( 3 patients )
SYNOVIAL DISORDER ( 3 patients )
HYPOTHYROIDISM ( 2 patients )
NEPHROLITHIASIS ( 2 patients )
ABDOMINAL DISTENSION ( 2 patients )
SUICIDE ATTEMPT ( 2 patients )
HYPERPARATHYROIDISM ( 2 patients )
INNER EAR DISORDER ( 1 patients )
MYOCARDIAL INFARCTION ( 1 patients )
EAR DISORDER ( 1 patients )
OSTEOPOROSIS PROPHYLAXIS ( 1 patients )
BLOOD PRESSURE DECREASED ( 1 patients )
FATTY ACID DEFICIENCY ( 1 patients )
FLUID IMBALANCE ( 1 patients )
CARDIAC FAILURE CONGESTIVE ( 1 patients )
GRAVITATIONAL OEDEMA ( 1 patients )
CHRONIC OBSTRUCTIVE PULMONARY DISEASE ( 1 patients )
URINE CALCIUM INCREASED ( 1 patients )
DEPRESSION ( 1 patients )
ELECTROLYTE SUBSTITUTION THERAPY ( 1 patients )
EYE SWELLING ( 1 patients )
POLYCYSTIC OVARIES ( 1 patients )
BLOOD PRESSURE INCREASED ( 1 patients )
FIBROMYALGIA ( 1 patients )
PREMENSTRUAL SYNDROME ( 1 patients )
CARDIAC FAILURE ( 1 patients )
CARPAL TUNNEL SYNDROME ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with ADHESION:

FOSAMAX (219 patients)
VIOXX (200 patients)
HUMIRA (129 patients)
REMICADE (102 patients)
PEGASYS (82 patients)
ACCUTANE (70 patients)
LIPITOR (58 patients)
NEURONTIN (55 patients)
ASPIRIN (46 patients)
AVONEX (45 patients)
SYNTHROID (44 patients)
PRILOSEC (42 patients)
LORAZEPAM (41 patients)
COPEGUS (40 patients)
FOLIC ACID (40 patients)
VITAMIN E (39 patients)
PAXIL (38 patients)
METHOTREXATE (37 patients)
CELEBREX (37 patients)
DIANEAL (37 patients)
PREMARIN (37 patients)
LISINOPRIL (32 patients)
HYDROCHLOROTHIAZIDE (31 patients)
LYRICA (30 patients)
FLOVENT (30 patients)
XANAX (28 patients)
LIORESAL (28 patients)
NORVASC (27 patients)
PREDNISONE (27 patients)
IBUPROFEN (27 patients)
ACTONEL (26 patients)
ALBUTEROL (26 patients)
[THERAPY UNSPECIFIED] (26 patients)
CALCIUM (UNSPECIFIED) (26 patients)
DIGOXIN (25 patients)
AMBIEN (25 patients)
PROTONIX (25 patients)
FUROSEMIDE (24 patients)
ATENOLOL (24 patients)
LASIX (23 patients)
OXYCONTIN (23 patients)
NEXIUM (23 patients)
FLEXERIL (22 patients)
ACETAMINOPHEN (21 patients)
FOSAMAX PLUS D (21 patients)
ZANTAC (21 patients)
ZOLOFT (21 patients)
EVISTA (21 patients)
VITAMIN D (21 patients)
CIPRO (20 patients)
LEVOTHYROXINE SODIUM (20 patients)
FORTEO (19 patients)
PREDNISONE TAB (19 patients)
LANOXIN (19 patients)
LEXAPRO (18 patients)
ACIPHEX (18 patients)
LORTAB (18 patients)
COUMADIN (18 patients)
OMEPRAZOLE (18 patients)
FLUOROURACIL (18 patients)
VERAPAMIL (17 patients)
VITAMINS (UNSPECIFIED) (17 patients)
PERCOCET (17 patients)
HYDROCODONE BITARTRATE (17 patients)
TRAZODONE HYDROCHLORIDE (17 patients)
CLARITIN (17 patients)
CLONAZEPAM (17 patients)
MULTI-VITAMIN (17 patients)
MYCOPHENOLATE MOFETIL (16 patients)
DETROL LA (16 patients)
ACETAMINOPHEN AND HYDROCODONE BITARTRATE (16 patients)
SEROQUEL (16 patients)
AMITRIPTYLINE HYDROCHLORIDE (16 patients)
AMPICILLIN (16 patients)
ZOFRAN (16 patients)
VALIUM (15 patients)
CYANOCOBALAMIN (14 patients)
ALPRAZOLAM (14 patients)
WARFARIN SODIUM (14 patients)
VICODIN (14 patients)
ACYCLOVIR (13 patients)
LEVAQUIN (13 patients)
ROBAXIN (13 patients)
ALENDRONATE SODIUM (13 patients)
DECADRON (13 patients)
MORPHINE (13 patients)
VITAMIN B-12 (13 patients)
BACTRIM DS (13 patients)
ZELNORM (13 patients)
CIMZIA (13 patients)
ENTOCORT EC (13 patients)
ALTACE (12 patients)
VENTOLIN (12 patients)
K-DUR 10 (12 patients)
LEUCOVORIN CALCIUM (12 patients)
CYMBALTA (12 patients)
DEXAMETHASONE (12 patients)
MIRENA (12 patients)
GOLIMUMAB (12 patients)
HORMONES (UNSPECIFIED) (12 patients)
PREVACID (12 patients)
PRIMIDONE (12 patients)
CITALOPRAM HYDROBROMIDE (12 patients)
FENTANYL (12 patients)
VYTORIN (12 patients)
VITAMIN D (UNSPECIFIED) (11 patients)
ZOCOR (11 patients)
PREDNISOLONE (11 patients)
DOXORUBICIN HCL (11 patients)
POTASSIUM CHLORIDE (11 patients)
OYST CAL D (11 patients)
FAMOTIDINE (11 patients)
REGLAN (11 patients)
WELLBUTRIN (11 patients)
GABAPENTIN (11 patients)
OXYCODONE HCL (11 patients)
ZETIA (11 patients)
DULCOLAX (11 patients)
URBASON (11 patients)
CLOZARIL (11 patients)
CLONIDINE (11 patients)
RANITIDINE (11 patients)
REBIF (10 patients)
PREMPRO (10 patients)
YAZ (10 patients)
CLONOPIN (10 patients)
ESTRATEST (10 patients)
VITAMINS (10 patients)
ASCORBIC ACID (10 patients)
TOCILIZUMAB (10 patients)
DEPAKOTE (10 patients)
MIACALCIN (10 patients)
DOSTINEX (10 patients)
BACLOFEN (10 patients)
CELEXA (10 patients)
NITROSTAT (10 patients)
LANTUS (10 patients)
CALCIUM (10 patients)
DIFLUCAN (9 patients)
ENBREL (9 patients)
ONDANSETRON (9 patients)
TEGRETOL (9 patients)
PROMETHAZINE (9 patients)
INDAPAMIDE (9 patients)
ADVAIR DISKUS 100/50 (9 patients)
PLAVIX (9 patients)
LANSOPRAZOLE (9 patients)
TACROLIMUS (9 patients)
AMOXICILLIN (9 patients)
IMURAN (9 patients)
MULTI-VITAMINS (9 patients)
DIOVAN (9 patients)
MORPHINE SULFATE (9 patients)
CENTRUM (9 patients)
BIRTH CONTROL PILLS (9 patients)
ESTRADIOL (9 patients)
CALCIUM GLUCONATE (9 patients)
LUPRON DEPOT (9 patients)
FISH OIL (9 patients)
DICLOFENAC (9 patients)
CALCIUM CARBONATE (9 patients)
LOVENOX (8 patients)
MIRALAX (8 patients)
SALAGEN (8 patients)
CELECOXIB (8 patients)
ULTRAM (8 patients)
DEPO-PROVERA (8 patients)
TRAZODONE HCL (8 patients)
SK-ERYTHROMYCIN (8 patients)
MIRAPEX (8 patients)
VALTREX (8 patients)
TYLENOL (CAPLET) (8 patients)
YASMIN (8 patients)
RENAGEL (8 patients)
SERTRALINE HYDROCHLORIDE (8 patients)
CRESTOR (8 patients)
CARTICEL (8 patients)
AUGMENTIN '125' (8 patients)
DICLOFENAC SODIUM (8 patients)
AVASTIN (8 patients)
PENTASA (8 patients)
VELCADE (8 patients)
VANCOMYCIN (8 patients)
VINCRISTINE (8 patients)
PROGRAF (8 patients)
FLAGYL (8 patients)
UNCODEABLE ^UNCLASSIFIABLE^ (7 patients)
ELIDEL (7 patients)
FLOXIN OTIC (7 patients)
ACTOS (7 patients)
CLINDAMYCIN (7 patients)
IMIPRAMINE (7 patients)
OXALIPLATIN (7 patients)
AMITRIPTYLINE HCL (7 patients)
CIPROFLOXACIN (7 patients)
NIFEDIPINE (7 patients)
LAMICTAL (7 patients)
COZAAR (7 patients)
WARFARIN (7 patients)
FLORINEF (7 patients)
METOPROLOL (7 patients)
HUMALOG (7 patients)
BEVACIZUMAB (7 patients)
ISONIAZID (7 patients)
KLONOPIN (7 patients)
PROZAC (7 patients)
CALCICHEW (7 patients)
PYRIDIUM (7 patients)
RAMIPRIL (7 patients)
NUVARING (7 patients)
Most common side effects for patients taking DYAZIDE:
PAIN (482 patients)
NAUSEA (467 patients)
ANXIETY (408 patients)
DYSPNOEA (388 patients)
DEPRESSION (379 patients)
FATIGUE (366 patients)
DIZZINESS (365 patients)
OEDEMA PERIPHERAL (334 patients)
HEADACHE (318 patients)
FALL (310 patients)
DIARRHOEA (306 patients)
ASTHENIA (302 patients)
VOMITING (288 patients)
DRUG INEFFECTIVE (272 patients)
HYPERTENSION (267 patients)
ARTHRALGIA (266 patients)
CHEST PAIN (254 patients)
PAIN IN EXTREMITY (235 patients)
ANAEMIA (232 patients)
CONSTIPATION (228 patients)
INJURY (219 patients)
BACK PAIN (219 patients)
CEREBROVASCULAR ACCIDENT (214 patients)
INSOMNIA (197 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (192 patients)
WEIGHT DECREASED (188 patients)
MYOCARDIAL INFARCTION (186 patients)
PNEUMONIA (185 patients)
HYPOAESTHESIA (175 patients)
COUGH (170 patients)
BONE DISORDER (167 patients)
OSTEOARTHRITIS (166 patients)
MYALGIA (166 patients)
URINARY TRACT INFECTION (165 patients)
BLOOD PRESSURE INCREASED (160 patients)
OSTEONECROSIS OF JAW (160 patients)
DEHYDRATION (158 patients)
ABDOMINAL PAIN (156 patients)
MUSCLE SPASMS (156 patients)
EMOTIONAL DISTRESS (156 patients)
RENAL FAILURE (154 patients)
PARAESTHESIA (150 patients)
ATRIAL FIBRILLATION (149 patients)
BRONCHITIS (146 patients)
PYREXIA (146 patients)
RASH (144 patients)
DEEP VEIN THROMBOSIS (143 patients)
OSTEOMYELITIS (143 patients)
CARDIAC FAILURE CONGESTIVE (139 patients)
GAIT DISTURBANCE (138 patients)
CELLULITIS (137 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (136 patients)
MITRAL VALVE INCOMPETENCE (135 patients)
WEIGHT INCREASED (133 patients)
CORONARY ARTERY DISEASE (133 patients)
TRANSIENT ISCHAEMIC ATTACK (132 patients)
SYNCOPE (131 patients)
PRURITUS (128 patients)
HAEMORRHOIDS (126 patients)
SINUSITIS (125 patients)
HAEMOGLOBIN DECREASED (124 patients)
MALAISE (124 patients)
INFECTION (123 patients)
BLOOD CHOLESTEROL INCREASED (118 patients)
BLOOD GLUCOSE INCREASED (117 patients)
TREMOR (117 patients)
PULMONARY EMBOLISM (116 patients)
PALPITATIONS (116 patients)
RENAL IMPAIRMENT (115 patients)
FEELING ABNORMAL (114 patients)
ABDOMINAL PAIN UPPER (110 patients)
ERYTHEMA (110 patients)
NEUROPATHY PERIPHERAL (109 patients)
OSTEONECROSIS (109 patients)
RENAL FAILURE ACUTE (109 patients)
DYSGEUSIA (108 patients)
PLEURAL EFFUSION (108 patients)
VISION BLURRED (107 patients)
OSTEOPOROSIS (107 patients)
HYPERSENSITIVITY (106 patients)
HYPOTENSION (106 patients)
BREAST CANCER (105 patients)
INTERVERTEBRAL DISC PROTRUSION (105 patients)
ARTHRITIS (104 patients)
CATARACT (104 patients)
DIABETES MELLITUS (103 patients)
BLOOD CREATININE INCREASED (101 patients)
SOMNOLENCE (100 patients)
MUSCULAR WEAKNESS (98 patients)
DYSPHAGIA (97 patients)
DECREASED APPETITE (97 patients)
CONFUSIONAL STATE (95 patients)
IMPAIRED HEALING (95 patients)
HYPERLIPIDAEMIA (94 patients)
SPINAL OSTEOARTHRITIS (93 patients)
DEATH (93 patients)
DYSPEPSIA (93 patients)
BALANCE DISORDER (93 patients)
TRICUSPID VALVE INCOMPETENCE (92 patients)
HYPERCHOLESTEROLAEMIA (89 patients)
CONDITION AGGRAVATED (88 patients)
ROTATOR CUFF SYNDROME (86 patients)
VENTRICULAR HYPERTROPHY (86 patients)
HEART RATE INCREASED (86 patients)
ATELECTASIS (85 patients)
OSTEOPENIA (85 patients)
HYPOKALAEMIA (83 patients)
HYPERHIDROSIS (81 patients)
SWELLING (80 patients)
BRADYCARDIA (80 patients)
CARDIAC DISORDER (79 patients)
INTERVERTEBRAL DISC DEGENERATION (79 patients)
CARDIOMEGALY (79 patients)
OEDEMA (79 patients)
DRY MOUTH (76 patients)
PHARMACEUTICAL PRODUCT COMPLAINT (76 patients)
CONTUSION (75 patients)
BASAL CELL CARCINOMA (74 patients)
ASTHMA (74 patients)
CHOLELITHIASIS (73 patients)
HYPOTHYROIDISM (73 patients)
TACHYCARDIA (72 patients)
CARDIAC MURMUR (71 patients)
FEMUR FRACTURE (71 patients)
DRUG INTERACTION (71 patients)
ABDOMINAL DISCOMFORT (70 patients)
DIVERTICULUM (70 patients)
THROMBOCYTOPENIA (70 patients)
HALLUCINATION (69 patients)
TOOTH EXTRACTION (69 patients)
FIBROMYALGIA (68 patients)
DRUG HYPERSENSITIVITY (68 patients)
MENTAL STATUS CHANGES (68 patients)
BLOOD POTASSIUM DECREASED (67 patients)
CONVULSION (67 patients)
MIGRAINE (67 patients)
JOINT SWELLING (67 patients)
RENAL CYST (67 patients)
FEAR (66 patients)
VISUAL ACUITY REDUCED (66 patients)
HAEMATOCRIT DECREASED (66 patients)
EXOSTOSIS (66 patients)
DYSURIA (65 patients)
STRESS (65 patients)
ORAL PAIN (65 patients)
DECREASED INTEREST (65 patients)
ANHEDONIA (65 patients)
LOSS OF CONSCIOUSNESS (65 patients)
PLATELET COUNT DECREASED (65 patients)
MUSCULOSKELETAL PAIN (64 patients)
ALOPECIA (63 patients)
GASTRITIS (63 patients)
PAIN IN JAW (62 patients)
BLOOD PRESSURE DECREASED (62 patients)
NECK PAIN (62 patients)
BURNING SENSATION (61 patients)
SWELLING FACE (61 patients)
GASTROINTESTINAL HAEMORRHAGE (61 patients)
DIVERTICULITIS (61 patients)
FLUSHING (59 patients)
HYPERGLYCAEMIA (59 patients)
GINGIVAL PAIN (58 patients)
TOOTH DISORDER (58 patients)
NERVOUSNESS (58 patients)
CARPAL TUNNEL SYNDROME (57 patients)
AMNESIA (57 patients)
ANGINA PECTORIS (57 patients)
LETHARGY (57 patients)
EPISTAXIS (57 patients)
RHEUMATOID ARTHRITIS (56 patients)
MEMORY IMPAIRMENT (56 patients)
BLOOD UREA INCREASED (56 patients)
ACUTE MYOCARDIAL INFARCTION (56 patients)
DYSPNOEA EXERTIONAL (56 patients)
BURSITIS (56 patients)
RIB FRACTURE (56 patients)
GINGIVAL RECESSION (56 patients)
ABDOMINAL DISTENSION (55 patients)
VERTIGO (55 patients)
RENAL FAILURE CHRONIC (55 patients)
OBESITY (54 patients)
HYPONATRAEMIA (54 patients)
TOOTH ABSCESS (54 patients)
URTICARIA (53 patients)
CHILLS (53 patients)
AORTIC ARTERIOSCLEROSIS (53 patients)
NEPHROLITHIASIS (52 patients)
CHEST DISCOMFORT (52 patients)
BONE PAIN (52 patients)
PANCYTOPENIA (52 patients)
AORTIC VALVE INCOMPETENCE (52 patients)
EYE PAIN (52 patients)
OVERDOSE (51 patients)
WHEEZING (51 patients)
TINNITUS (51 patients)
MUSCULOSKELETAL CHEST PAIN (50 patients)
LYMPHADENOPATHY (50 patients)
SINUS BRADYCARDIA (50 patients)
TOOTH LOSS (50 patients)
TOOTHACHE (50 patients)
ECONOMIC PROBLEM (50 patients)
UNEVALUABLE EVENT (49 patients)
ARTERIOSCLEROSIS (49 patients)
DRY SKIN (48 patients)
STOMATITIS (48 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (48 patients)
PURULENT DISCHARGE (48 patients)
HIATUS HERNIA (47 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (47 patients)
SPINAL COLUMN STENOSIS (46 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for DYAZIDE


Issue Description / Topic Timestamp
QUESTION
HYPERTHYROIDISM
I was taking Dyazide for high blood pressure for over a year. When all of a sudden on July 5, 2014 I developed A Fib. I went to the hospital and dr. diagnosed me with Hyperthyroidism. This was sudden. Can Dyazide cause Hyperthyroidism? 2015-07-04 09:47:13

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about ADHESION and DYAZIDE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking DYAZIDE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in DYAZIDE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for DYAZIDE experts. If you are a healthcare provider experienced in prescribing DYAZIDE, please register here.
giCould not connect: